On average, they expect fate therapeutics' share price to reach $107.83 in the next twelve months. Find the latest fate therapeutics, inc.
View the latest fate therapeutics inc.
Fate stock price target. Based on data from marketbeat, fate therapeutics has an average rating of buy and a consensus price target of $107.26. Wells fargo & company has the lowest price target set, forecasting a price of $45.00 for fastenal in the next year. 403,89 $ spread / average target:
466,00 $ spread / highest target: Learn more on fast's analyst rating history do wall street analysts like fastenal more than its competitors? The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00.
This suggests a possible upside of 92.7% from the stock's current price. The average price target represents a. 1 wall street analysts that have issued a 1 year fat price target, the average fat price target is $25.00, with the highest fat stock price forecast at $25.00 and the lowest fat stock price forecast at $25.00.
306,84 $ average target price: 3 wall street analysts that have issued a 1 year fast price target, the average fast price target is $48.33, with the highest fast stock price forecast at $52.00 and the lowest fast stock price forecast at $45.00. 23 rows the trend in the analyst price target fate's average price target has.
The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The company's stock had a. 30, 2021 at 6:15 p.m.
This price target is based on 4 analysts offering 12 month price targets for fast retailing in the last 3 months. Stephens has the highest price target set, predicting fast will reach $65.00 in the next twelve months. Based on analysts offering 12 month price targets for fate in the last 3 months.
125 rows jefferies financial group inc. (fate) stock quote, history, news and other vital information to help you with your stock trading and investing. Has the highest price target set, predicting fate will.
The average price target is $100.00 with a high forecast of $145.00 and a low forecast of $60.00. The average price target represents a 93.16% change from the last price of $51.77. Et on gurufocus.com recent poor results have.
Fate therapeutics inc (fate) cfo edward j dulac iii sold $1.2 million of shares sep. 8 wall street analysts that have issued a 1 year fate price target, the average fate price target is $106.63, with the highest fate stock price forecast at $130.00 and the lowest fate stock price forecast at $77.00. Their forecasts range from $60.00 to $145.00.
Shares of fate therapeutics ( nasdaq:fate) were skyrocketing 47.3% higher as of 11:43 a.m. (fate) stock price, news, historical charts, analyst ratings and financial information from wsj. Five research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock.
Based on 9 wall street analysts offering 12 month price targets for fate therapeutics in the last 3 months.
0 komentar:
Posting Komentar